Zydus Pharmaceuticals (USA) Inc.

Zydus Pharmaceuticals (USA) Inc. is the United States generic drug division of Zydus Lifesciences Limited, a global, fully integrated pharmaceutical company headquartered in Ahmedabad, India. The company focuses on the marketing and distribution of generic and authorized generic pharmaceutical products, including complex generics such as modified-release solid orals, transdermals, injectables, and oral suspensions. Operating as a 100% subsidiary of Zydus Lifesciences, the U.S. entity leverages its parent company's extensive R&D capabilities, which include over 1,500 scientists globally. Zydus is recognized as a significant player in the U.S. generic market, consistently ranking among the top generic corporations by dispensed prescriptions, and is actively expanding into novel therapeutics, biosimilars, and rare disease portfolios.